Suppr超能文献

[因印多蒂内毛癣菌引起的持续性皮肤真菌病]

[Persistent dermatomycosis due toTrichophyton indotineae].

作者信息

Buil Jochem B, Meijer Eelco F J, den Reijer Martijn, Zeeuwen-Franssen Manon E J, Melchers Willem J G, Verweij Paul E

机构信息

Radboudumc, afd. Medische Microbiologie, Nijmegen.

Contact:

出版信息

Ned Tijdschr Geneeskd. 2024 Jul 23;168:D7945.

Abstract

is a recently identified dermatophyte that frequently causes extensive and persistent dermatomycosis, particularly tinea corporis, tinea cruris, and tinea faciei. The infection is frequently encountered in countries of the Indian subcontinent and surrounding areas. In Europe, has mainly been detected in patients with an epidemiological link to the aforementioned regions. Unlike dermatomycoses caused by other dermatophyte species, infections caused by often exhibit treatment failure with commonly prescribed antifungal drugs. Reduced susceptibility to terbinafine is often observed in . In addition, reduced susceptibility to itraconazole has also been reported. Due to the extensive and persistent nature of the infection, as well as the reduced susceptibility to antifungal drugs, international experts recommend aggressive treatment of using a combination of oral and topical antifungals. Susceptibility testing may be warranted to guide treatment decisions. Early recognition of infections is crucial to prevent prolonged recurrences.

摘要

是一种最近被鉴定出的皮肤癣菌,常引起广泛且持续的皮肤真菌病,尤其是体癣、股癣和面癣。在印度次大陆及周边地区的国家,这种感染很常见。在欧洲,主要在与上述地区有流行病学关联的患者中检测到。与其他皮肤癣菌引起的皮肤真菌病不同,由该菌引起的感染通常对常用的抗真菌药物治疗无效。在该菌中常观察到对特比萘芬的敏感性降低。此外,也有报道称对伊曲康唑的敏感性降低。由于感染具有广泛性和持续性,以及对抗真菌药物的敏感性降低,国际专家建议使用口服和外用抗真菌药物联合积极治疗该菌感染。可能需要进行药敏试验以指导治疗决策。早期识别该菌感染对于防止长期复发至关重要。

相似文献

1
[Persistent dermatomycosis due toTrichophyton indotineae].
Ned Tijdschr Geneeskd. 2024 Jul 23;168:D7945.
2
Antifungal resistance in dermatophytes - review of the epidemiology, diagnostic challenges and treatment strategies for managing infections.
Expert Rev Anti Infect Ther. 2024 Sep;22(9):739-751. doi: 10.1080/14787210.2024.2390629. Epub 2024 Aug 18.
3
Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae.
JAMA Dermatol. 2024 Jul 1;160(7):701-709. doi: 10.1001/jamadermatol.2024.1126.
4
Clinical alert: arrival of terbinafine resistant Trichophyton indotineae in New Zealand.
N Z Med J. 2025 Feb 28;138(1610):31-38. doi: 10.26635/6965.6815.
5
Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae.
J Am Acad Dermatol. 2024 Aug;91(2):315-323. doi: 10.1016/j.jaad.2024.03.024. Epub 2024 Apr 3.
7
A systematic review on the emergence of terbinafine-resistant Trichophyton indotineae in Europe: Time to act?
J Eur Acad Dermatol Venereol. 2025 Feb;39(2):364-376. doi: 10.1111/jdv.20270. Epub 2024 Jul 31.
9
Terbinafine Resistant Isolated in Patients With Superficial Dermatophyte Infection in Canadian Patients.
J Cutan Med Surg. 2022 Jul-Aug;26(4):371-376. doi: 10.1177/12034754221077891. Epub 2022 Feb 10.
10
Tinea universalis due to Trichophyton indotineae in an adult male.
Indian J Med Microbiol. 2023 Nov-Dec;46:100476. doi: 10.1016/j.ijmmb.2023.100476. Epub 2023 Oct 6.

引用本文的文献

1
Autochthonous transmission of through sexual contact, France, 2024.
Euro Surveill. 2025 Jul;30(26). doi: 10.2807/1560-7917.ES.2025.30.26.2500416.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验